Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Computer algorithms can tell apart the drugs that provide effective pain relief from ineffective placebos, Oxford's Centre for Functional MRI of the Brain has found.

More than 90% of central nervous system drugs fail when they're tried in large human trials.

The team at the Oxford Centre for Functional MRI of the Brain (FMRIB) hope that combining information from many brain imaging studies with their computational methods will provide a cheaper way of filtering out drugs that are not likely to work, without the need for expensive human clinical trials.

Many drugs, such as those for pain relief, work on the central nervous system: they cross into the brain and directly affect its function. But drug effects are often subtle, and the same drug can have varying effects on different people.

There is a great need for markers that can help to prioritise and direct drug research prior to full-scale clinical trials. - Dr Eugene Duff

As a result, it is difficult to work out whether a new drug is likely to be effective enough to justify further development: testing it in many people takes time and is expensive. The study, led by Eugene Duff, included more than 130 people, and is published in Science Translational Medicine.

Read more on the University website...

Similar stories

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Magnetic signatures of the brain characterised in UK Biobank imaging study

A study published this week in Nature Neuroscience demonstrates how studying the magnetic properties of tissue may provide a unique window into brain health and disease.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Professor Irene Tracey nominated as Vice-Chancellor of the University of Oxford

Professor of Anaesthetic Neuroscience Irene Tracey, former head of the Nuffield Department of Clinical Neurosciences, has been nominated as the next Vice-Chancellor of the University of Oxford.

Little understood brain region linked to how we perceive pain

A new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.

Brain regions related to smell show decline following mild COVID-19

Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.